{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T04:31:43Z","timestamp":1792816303737,"version":"4.5.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T00:00:00Z","timestamp":1552003200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1245\/s10434-019-07272-4","type":"journal-article","created":{"date-parts":[[2019,3,8]],"date-time":"2019-03-08T11:18:28Z","timestamp":1552043908000},"page":"2417-2427","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Low Risk of Development of a Regional Recurrence After an Unsuccessful Repeat Sentinel Lymph Node Biopsy in Patients with Ipsilateral Breast Tumor Recurrence"],"prefix":"10.1245","volume":"26","author":[{"name":"the Sentinel Node And Recurrent Breast Cancer (SNARB) study group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9137-7599","authenticated-orcid":false,"given":"Ingrid G. M.","family":"Poodt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coco J. E. F.","family":"Walstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guusje","family":"Vugts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana J. G.","family":"Maaskant-Braat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri C.","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert-Jan","family":"Schipper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grard A. P.","family":"Nieuwenhuijzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,8]]},"reference":[{"key":"7272_CR1","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1245\/s10434-015-4787-6","volume":"22","author":"G Vugts","year":"2015","unstructured":"Vugts G, Maaskant-Braat AJG, Voogd AC, et al. Improving the success rate of repeat sentinel node biopsy in recurrent breast cancer. Ann Surg Oncol. 2015;22:529\u201335.","journal-title":"Ann Surg Oncol."},{"key":"7272_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s10549-013-2409-1","volume":"138","author":"AJ Maaskant-Braat","year":"2013","unstructured":"Maaskant-Braat AJ, Voogd AC, Roumen RM, Nieuwenhuijzen GA. Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature. Breast Cancer Res Treat. 2013;138:13\u201320.","journal-title":"Breast Cancer Res Treat."},{"key":"7272_CR3","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1245\/s10434-018-6358-0","volume":"25","author":"IGM Poodt","year":"2018","unstructured":"Poodt IGM, Vugts G, Schipper RJ, Nieuwenhuijzen GAP. Repeat sentinel lymph node biopsy for ipsilateral breast tumor recurrence: a systematic review of the results and impact on prognosis. Ann Surg Oncol. 2018;25:1329\u201339.","journal-title":"Ann Surg Oncol."},{"key":"7272_CR4","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/0360-3016(94)90312-3","volume":"30","author":"JH Borger","year":"1994","unstructured":"Borger JH, Kemperman H, Smitt HS, et al. Dose and volume effects on fibrosis after breast conservation therapy. Int J Radiat Oncol Biol Phys. 1994;30:1073\u201381.","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"7272_CR5","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.radonc.2013.07.006","volume":"108","author":"MB Mukesh","year":"2013","unstructured":"Mukesh MB, Harris E, Collette S, et al. Normal tissue complication probability (NTCP) parameters for breast fibrosis: pooled results from two randomised trials. Radiother Oncol. 2013;108:293\u20138.","journal-title":"Radiother Oncol."},{"key":"7272_CR6","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1245\/s10434-018-6384-y","volume":"25","author":"IGM Poodt","year":"2018","unstructured":"Poodt IGM, Vugts G, Maaskant-Braat AJG, et al. Risk of regional recurrence after negative repeat sentinel lymph node biopsy in patients with ipsilateral breast tumor recurrence. Ann Surg Oncol. 2018;25:1312\u201321.","journal-title":"Ann Surg Oncol."},{"key":"7272_CR7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1245\/s10434-015-5003-4","volume":"23","author":"S Ugras","year":"2016","unstructured":"Ugras S, Matsen C, Eaton A, et al. Reoperative sentinel lymph node biopsy is feasible for locally recurrent breast cancer, but is it worthwhile? Ann Surg Oncol. 2016;23:744\u20138.","journal-title":"Ann Surg Oncol."},{"key":"7272_CR8","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s10549-015-3571-4","volume":"153","author":"G Vugts","year":"2015","unstructured":"Vugts G, Maaskant-Braat AJG, Voogd AC, et al. Repeat sentinel node biopsy should be considered in patients with locally recurrent breast cancer. Breast Cancer Res Treat. 2015;153:549\u201356.","journal-title":"Breast Cancer Res Treat."},{"key":"7272_CR9","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1245\/s10434-012-2625-7","volume":"20","author":"AJG Maaskant-Braat","year":"2013","unstructured":"Maaskant-Braat AJG, Roumen RMH, Voogd AC, et al. Sentinel node and recurrent breast cancer (SNARB): results of a nationwide registration study. Ann Surg Oncol. 2013;20:620\u20136.","journal-title":"Ann Surg Oncol."},{"key":"7272_CR10","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/j.ejso.2015.05.015","volume":"41","author":"M Moossdorff","year":"2015","unstructured":"Moossdorff M, Vugts G, Maaskant-Braat AJ, et al. Contralateral lymph node recurrence in breast cancer: regional event rather than distant metastatic disease. A systematic review of the literature. Eur J Surg Oncol. 2015;41:1128\u201336.","journal-title":"Eur J Surg Oncol."},{"key":"7272_CR11","doi-asserted-by":"publisher","unstructured":"Moossdorff M, van Roozendaal LM, Strobbe LJ, et al. Maastricht Delphi consensus on event definitions for classification of recurrence in breast cancer research. J Natl Cancer Inst. 2014. https:\/\/doi.org\/10.1093\/jnci\/dju288","DOI":"10.1093\/jnci\/dju288"},{"key":"7272_CR12","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.ejso.2011.01.024","volume":"37","author":"B Morcos","year":"2011","unstructured":"Morcos B, Jaradat I, El-Ghanem M. Characteristics of and therapeutic options for contralateral axillary lymph node metastasis in breast cancer. Eur J Surg Oncol. 2011;37:418\u201321.","journal-title":"Eur J Surg Oncol."},{"key":"7272_CR13","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1200\/JCO.2006.10.3523","volume":"25","author":"CA Hudis","year":"2007","unstructured":"Hudis CA, Barlow WE, Costantino JP, et al. Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: the STEEP system. J Clin Oncol. 2007;25:2127\u201332.","journal-title":"J Clin Oncol"},{"key":"7272_CR14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/S1470-2045(13)70589-8","volume":"15","author":"S Aebi","year":"2014","unstructured":"Aebi S, Gelber S, Anderson SJ, et al. Chemotherapy for isolated locoregional recurrence of breast cancer (CALOR): a randomised trial. Lancet Oncol. 2014;15:156\u201363.","journal-title":"Lancet Oncol."},{"key":"7272_CR15","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10549-017-4340-3","volume":"165","author":"YM Geurts","year":"2017","unstructured":"Geurts YM, Witteveen A, Bretveld R, et al. Patterns and predictors of first and subsequent recurrence in women with early breast cancer. Breast Cancer Res Treat. 2017;165:709\u201320.","journal-title":"Breast Cancer Res Treat."},{"key":"7272_CR16","doi-asserted-by":"crossref","unstructured":"Wapnir IL, Price KN, Anderson SJ, et al. Efficacy of chemotherapy for ER-negative and ER-positive isolated locoregional recurrence of breast cancer: final analysis of the CALOR Trial. J Clin Oncol. 2018; JCO2017765719.","DOI":"10.1200\/JCO.2017.76.5719"},{"key":"7272_CR17","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.ejso.2016.12.011","volume":"43","author":"A Savolt","year":"2017","unstructured":"Savolt A, Peley G, Polgar C, et al. Eight-year follow up result of the OTOASOR trial: the Optimal Treatment Of the Axilla\u2014Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: a randomized, single centre, phase III, non-inferiority trial. Eur J Surg Oncol. 2017;43:672\u20139.","journal-title":"Eur J Surg Oncol."},{"key":"7272_CR18","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/S1470-2045(14)70460-7","volume":"15","author":"M Donker","year":"2014","unstructured":"Donker M, van Tienhoven G, Straver ME, et al. Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial. Lancet Oncol. 2014;15:1303\u201310.","journal-title":"Lancet Oncol."},{"key":"7272_CR19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1001\/jama.2011.90","volume":"305","author":"AE Giuliano","year":"2011","unstructured":"Giuliano AE, Hunt KK, Ballman KV, et al. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA. 2011;305:569\u201375.","journal-title":"JAMA."},{"key":"7272_CR20","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1245\/s10434-014-4282-5","volume":"22","author":"M Intra","year":"2015","unstructured":"Intra M, Viale G, Vila J, et al. Second axillary sentinel lymph node biopsy for breast tumor recurrence: experience of the european institute of oncology. Ann Surg Oncol. 2015;22:2372\u20137.","journal-title":"Ann Surg Oncol."},{"key":"7272_CR21","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.breast.2012.06.013","volume":"21","author":"O Gentilini","year":"2012","unstructured":"Gentilini O, Veronesi U. Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: Sentinel node vs Observation after axillary UltraSouND). Breast. 2012;21:678\u201381.","journal-title":"Breast."},{"key":"7272_CR22","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.clon.2015.07.005","volume":"27","author":"A Goyal","year":"2015","unstructured":"Goyal A, Dodwell D. POSNOC: a randomised trial looking at axillary treatment in women with one or two sentinel nodes with macrometastases. Clin Oncol (R Coll Radiol). 2015;27:692\u20135.","journal-title":"Clin Oncol (R Coll Radiol)."},{"key":"7272_CR23","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1186\/s12885-017-3443-x","volume":"17","author":"LM Roozendaal van","year":"2017","unstructured":"van Roozendaal LM, Vane MLG, van Dalen T, et al. Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08). BMC Cancer. 2017;17:459.","journal-title":"BMC Cancer."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07272-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07272-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07272-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T10:59:56Z","timestamp":1663066796000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07272-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["7272"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07272-4","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,8]]},"assertion":[{"value":"7 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"Research done for this study complies with the current laws of The Netherlands.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Standard"}}]}}